Tag Archives: Warren Woessner

Appellate Court Ruling Permits Continued NIH Funding of Embryonic Stem Cell Research

On August 24th, the D.C. Cir. ruling dismissing the suit brought to block any federal funding of embryonic stem cell research was affirmed. Stem cell researchers can breathe a bit more easily, and keep the lights on in their labs … Continue reading

Posted in Stem Cells/Cloning | Tagged , , | Leave a comment

Admissibility of Disclaimers – New Lessons From The EPO Technical Boards of Appeal

The following is a guest post from the 8/12 newsletter of Dr. Stefan Danner of DHS Patentanwaltsgesellschaft mbH.  Last year, the EPO Enlarged Board of Appeal (EBA) handed down its decision in case G2/10 relating to the admissibility of disclaimers whose … Continue reading

Posted in EP and UK Practice | Tagged , , , , , , , , | Leave a comment

Federal Circuit Opinion On Myriad Remand

Today, the Federal Circuit issued its opinion following GVR from the Supreme Court in AMP v. USPTO and Myriad Genetics, Inc., App. No. 2010-1406 (August 16,2012). (A copy of the opinion is available at the end of this post.) Unfortunately, … Continue reading

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , , | 1 Comment

USPTO Publishes Rule Package on AIA Administrative Trials

While this is primarily a biotechnology patent law blog, the USPTO’s high level of rule making activity deserves attention, as it will affect us all after the September 16th deadline for implementing many of the new features of the AIA … Continue reading

Posted in AIA Patent Reform | Tagged , , , , , , , | Leave a comment